An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in users administering substances of uncertain source.
Several experts stated the demand for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Content Elimination
According to TikTok, the platform has removed problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Trading Operations
Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or administering at residence.
Within minutes of joining one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts show dark colored parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Oversight and Safety Measures
A representative for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.
